ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2265 for:    parkinson's disease[ALL-FIELDS]
Previous Study | Return to List | Next Study

Nocturnal Parkinson's Disease Symptoms Study Group

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01662427
Recruitment Status : Completed
First Posted : August 10, 2012
Last Update Posted : August 20, 2013
Sponsor:
Information provided by (Responsible Party):
Roongroj Bhidayasiri, Chulalongkorn University

Brief Summary:
To study associate factor of Noctural Parkinson's Disease Symptoms and quality of life in Parkinson's disease patients and caregivers.

Condition or disease Intervention/treatment
Parkinson's Disease Other: Questionaire to assess Noctural Parkinson's Disease Symptoms

Study Type : Observational
Actual Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Nocturnal Parkinson's Disease Symptoms Study Group
Study Start Date : November 2012
Actual Primary Completion Date : August 2013
Actual Study Completion Date : August 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
Questionniare Other: Questionaire to assess Noctural Parkinson's Disease Symptoms
Questionaire to assess Noctural Parkinson's Disease Symptoms and quality of life



Primary Outcome Measures :
  1. To assess Noctural Parkinson's Disease Symptoms

Secondary Outcome Measures :
  1. To assess quality of life in Parkinson's Disease patient
  2. To assess quality of life in caregiver of Parkinson's Disease patient


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Parkinson's disease patient and care givers
Criteria

Inclusion Criteria:

Idiopathic Parkinson's disease patient

Exclusion Criteria:

  1. Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis
  2. Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
  3. Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01662427


Locations
Thailand
Roongroj Bhidayasiri
Pathumwan, Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University

Responsible Party: Roongroj Bhidayasiri, Associate Professor, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT01662427     History of Changes
Other Study ID Numbers: 6222012
First Posted: August 10, 2012    Key Record Dates
Last Update Posted: August 20, 2013
Last Verified: August 2013

Keywords provided by Roongroj Bhidayasiri, Chulalongkorn University:
Quality of life
Noctural Parkinson's Disease Symptoms

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases